Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex de Crespigny

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Nuclear Medicine Technology|October 13, 2019
Optimization of <sup>89</sup>Zr PET Imaging for Improved Multisite Quantification and Lesion Detection Using an Anthropomorphic PhantomPaul E Christian, Simon-Peter Williams, Lance Burrell, et al.
Magnetic Resonance in Medicine|February 27, 2016
Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial populationJill Fredrickson, Natalie J Serkova, Shelby K Wyatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2024
Automated Lugano Metabolic Response Assessment in <sup>18</sup>F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission TomographySkander Jemaa, Souhila Ounadjela, Xiaoyong Wang, et al.
Investigational New Drugs|April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2022
Correction to: Preclinical development of ZED8, an <sup>89</sup>Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter StudyAlexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
Nature Medicine|November 28, 2018
<sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerFrederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Nuclear Medicine Technology|October 13, 2019
Optimization of <sup>89</sup>Zr PET Imaging for Improved Multisite Quantification and Lesion Detection Using an Anthropomorphic PhantomPaul E Christian, Simon-Peter Williams, Lance Burrell, et al.
Magnetic Resonance in Medicine|February 27, 2016
Clinical translation of ferumoxytol-based vessel size imaging (VSI): Feasibility in a phase I oncology clinical trial populationJill Fredrickson, Natalie J Serkova, Shelby K Wyatt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2024
Automated Lugano Metabolic Response Assessment in <sup>18</sup>F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission TomographySkander Jemaa, Souhila Ounadjela, Xiaoyong Wang, et al.
Investigational New Drugs|April 26, 2019
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumorsGeoffrey I Shapiro, Patricia LoRusso, Eunice Kwak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 25, 2022
Correction to: Preclinical development of ZED8, an <sup>89</sup>Zr immuno‑PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an <sup>89</sup>Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter StudyAlexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, et al.
Nature Medicine|November 28, 2018
<sup>89</sup>Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancerFrederike Bensch, Elly L van der Veen, Marjolijn N Lub-de Hooge, et al.
Pageof 3